PCRX SCHEDULE 13G/A: SEC filing

A Schedule 13G/A amendment was

Filed with the SEC on Oct 30, 2026 · accession 0002100119-26-001682

PCRX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 30, 2026. A Schedule 13G/A amendment was filed regarding beneficial ownership of Pacira BioSciences (PCRX) common stock. The stock moved +0.0% by the first close after the filing.

Summary of the filing

A Schedule 13G/A amendment was filed regarding beneficial ownership of Pacira BioSciences (PCRX) common stock. The filing text provided contains only the EDGAR directory listing and does not include the substantive ownership details.

For details, click here →

Key details

IssuerPacira BioSciences, Inc.

How PCRX stock reacted

Close before

$36.39

Oct 29, 2026

First close after

+0.00%

$36.39

5 trading days

+0.08%

$36.42

Since filing

+0.11%

$36.43

✦ Ask GOAX AI about this filing — what it means for PCRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PCRX?

Click here

Frequently asked questions

What did PCRX file with the SEC on Oct 30, 2026?

PCRX filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding beneficial ownership of Pacira BioSciences (PCRX) common stock. The filing text provided contains only the EDGAR directory listing and does not include the substantive ownership details.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did PCRX stock react to this filing?

PCRX closed at $36.39 before the filing and $36.39 on Oct 30, 2026 (+0.00%). Five trading days later: $36.42 (+0.08%).

Other PCRX SEC filings

Get alerts when PCRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

PCRX overview PCRX analysis PCRX news Latest SEC filings